|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR969 |
|
Date of registration:
|
11/05/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Observational study
End organ damage in patients with hypertenion: a magnetic resonance imaging approach.
|
|
Scientific title:
|
N/A - N/A |
|
Date of first enrolment:
|
17/10/2007 |
|
Target sample size:
|
200 |
|
Recruitment status: |
recruiting |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=969 |
|
Study type:
|
observational |
|
Study design:
|
Randomised: No; Masking: [default]; Control: Not applicable; Group: [default]; Type: [default]
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
A.
Brandts |
|
Address:
|
Leiden Univesity Medical Centre
Department of Radiology, C- 02-S
PO Box 9600
2300 RC
Leiden
The Netherlands |
|
Telephone:
|
+31 71-526 3657 |
|
Email:
|
a.brandts@lumc.nl |
|
Affiliation:
|
|
|
|
Name:
|
A.
Brandts |
|
Address:
|
Leiden Univesity Medical Centre
Department of Radiology, C- 02-S
PO Box 9600
2300 RC
Leiden
The Netherlands |
|
Telephone:
|
+31 71-526 3657 |
|
Email:
|
a.brandts@lumc.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Age > 18 years;
2. Patients with proven hypertension (i.e. blood pressure of > 140/90mmHg on repeated examination according to (8)).
Exclusion criteria: 1. Routine MRI-contraindications (e.g. instable metal implants, pacemaker/ICD, vascular clips, atrial fibrillation or sustained ventricular tachycardia pregnancy and claustrophobia).
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
Hypertension, 3T MRI, Organ failure
|
|
Intervention(s)
|
|
MR assesment heart, aorta and brain.
|
|
Primary Outcome(s)
|
|
Exact manifestations of organ damage in heart, aorta and brain in patients with hypertension.
|
|
Secondary Outcome(s)
|
|
Adjusted risk profiles on cardiovascular diseases.
|
|
Source(s) of Monetary Support
|
|
Leiden University Medical Center (LUMC), Dutch insurance companies
|
|